| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Journal of Clinical Endocrinology & Metabolism, Vol 59, 139-141, Copyright © 1984 by Endocrine Society
ARTICLES |
E Stone, LA Leiter, JR Lambert, JD Silverberg, KN Jeejeebhoy and GN Burrow
Because the exact site of thyroid hormone absorption in man is not known, we assessed the absorption of oral [125I]Na-L-T4 in patients with varying lengths of intact bowel and correlated this absorption with bowel length. Two normal subjects and five patients with surgical bowel resections, all of whom were euthyroid, were studied. Each received a tracer dose of [125I]Na-L-T4 orally, and serial samples of serum were assayed for radioactivity both with and without butanol extraction. The peak serum radioactivity in normal subjects occurred 2 h post ingestion and was 15% and 17% of the administered dose per liter serum and 11% and 13%/liter serum in butanol-extracted serum, respectively. In patients with shortened bowel, the peak radioactivity both in serum and butanol extracted serum was decreased, ranging from 2%-7% and 0%-5%/liter, respectively. There was no absorption of labeled T4 in the patient with a duodenum only. No consistent relationship was found between absorption and bowel length distal to the duodenum.
This article has been cited by other articles:
![]() |
E. S. Siraj, M. K. Gupta, and S. S. K. Reddy Raloxifene Causing Malabsorption of Levothyroxine Arch Intern Med, June 9, 2003; 163(11): 1367 - 1370. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. D. Toft Thyroxine Therapy N. Engl. J. Med., July 21, 1994; 331(3): 174 - 180. [Full Text] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Endocrinology | Endocrine Reviews | J. Clin. End. & Metab. |
| Molecular Endocrinology | Recent Prog. Horm. Res. | All Endocrine Journals |